2m 2m 2m 2m 2m 2m 2m
ADIAL PHRMCTCLS (ADIL)
NASDAQ
$2.53-$0.02 (-0.71%)
Price as of Jun 23, 2026 6:59 PM EDT- $5.9MMarket Cap
- -58.78%1-Year Change
- BiotechnologyIndustry
ADIAL PHRMCTCLS (ADIL)
$2.53-$0.02 (-0.71%)
ADIL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.55 | ||
Change | +$0.11 (+4.23%) | ||
Open | $2.62 | ||
High | $2.72 | ||
Low | $2.54 | ||
Previous Close | $2.71 | ||
Volume | 56,338 | ||
30-Day Average Volume | 1,227,290 | ||
1-Week Change | -4.91% | ||
1-Month Change | 30.29% | ||
1-Year Change | -58.78% | ||
3-Year Change | -98.19% | ||
5-Year Change | -99.86% | ||
Fundamentals | |||
Shares Outstanding | 2.2M | ||
Total Assets | $5.2M | ||
Market Cap | $5.9M | ||
Enterprise Value | $1.3M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$1.6M | ||
EBIT | $0.00 | ||
EBITDA | $141.00 | ||
Net Working Capital | $3.3M | ||
EPS | -$1.48 | ||
Enterprise Value/EBITDA | 9,551 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -2 | ||
PEG | N/A | ||
Price/Free Cash Flow | -4 | ||
Price/Operating Cash Flow | -4 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 02/06/2026 | ||
Earnings & Revenue